SCHEMBL9574656

SCHEMBL9574656

CCOc1ccc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)c3ccc(OC(=O)NCCOC(C)=O)nc3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
CACNA1B Q00975 1/20 0.45
APBA1 Q02410 1/20 0.45
HTT P42858 1/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
CA7 P43166 1/20 0.43
CA14 Q9ULX7 1/20 0.43
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CA12 O43570 1/20 0.41
PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7870517 0.93 MAPT (0.49) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL7867688 0.92 SMN1; SMN2 (0.46) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL7869440 0.91 MEN1 (0.45) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL7870590 0.90 MAPT (0.49) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL9574710 0.90 EGFR (0.49) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL8869525 0.89 MAPT (0.49) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL7862837 0.89 POLB (0.43) SMN1; SMN2KMT2AMEN1CACNA1BAPBA1
SCHEMBL7862714 0.87 ALDH1A1 (0.45) KMT2AMEN1CACNA1BAPBA1CA1
SCHEMBL7869444 0.86 KMT2A (0.53) MAPTNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL9018552 0.86 MAPT (0.49) MAPTNPC1RAB9ASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed